| 1 | 2526923 | A prolactin-inducible gene product which is a member of the calpactin/lipocortin family. | Mol Endocrinol | 1989 May |
3 |
| 2 | 2988922 | Factors affecting the conversion of androstenedione to estrogens by human fetal hepatocytes in monolayer culture. | Endocrinology | 1985 Jul |
3 |
| 3 | 7826796 | Midazolam is metabolized by at least three different cytochrome P450 enzymes. | Br J Anaesth | 1994 Nov |
1 |
| 4 | 7883227 | Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. | Gut | 1995 Feb |
3 |
| 5 | 8043020 | Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily. | Biochem Pharmacol | 1994 Jul 5 |
3 |
| 6 | 8070855 | Characterization of the human cytochrome P450 isozymes responsible for styrene metabolism. | IARC Sci Publ | 1993 |
1 |
| 7 | 8185679 | Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. | Biochem Pharmacol | 1994 Apr 29 |
6 |
| 8 | 8569713 | Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. | Mol Pharmacol | 1996 Jan |
3 |
| 9 | 8632764 | Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. | Mol Pharmacol | 1996 Feb |
2 |
| 10 | 8717162 | Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours. | Naunyn Schmiedebergs Arch Pharmacol | 1996 Jan |
2 |
| 11 | 8844805 | Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines. | Princess Takamatsu Symp | 1995 |
6 |
| 12 | 8946469 | Selective expression of CYP3A5 and not CYP3A4 in human blood. | Pharmacogenetics | 1996 Oct |
1 |
| 13 | 9145912 | Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. | Mol Pharmacol | 1997 May |
1 |
| 14 | 9157990 | Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. | Cancer Res | 1997 May 15 |
2 |
| 15 | 9202751 | The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. | Mutat Res | 1997 May 12 |
4 |
| 16 | 9321523 | In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. | Drug Metab Dispos | 1997 Oct |
2 |
| 17 | 9531517 | Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450. | Drug Metab Dispos | 1998 Apr |
1 |
| 18 | 9584328 | Cytochrome P450 specificity of metabolism and interactions of oxybutynin in human liver microsomes. | Pharmacol Toxicol | 1998 Apr |
5 |
| 19 | 9616191 | Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. | Drug Metab Dispos | 1998 Jun |
2 |
| 20 | 9626925 | Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data. | Eur J Clin Pharmacol | 1998 Apr |
2 |
| 21 | 9840430 | Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. | Naunyn Schmiedebergs Arch Pharmacol | 1998 Nov |
1 |
| 22 | 9929499 | Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver. | Drug Metab Dispos | 1999 Feb |
2 |
| 23 | 9929500 | Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression. | Drug Metab Dispos | 1999 Feb |
2 |
| 24 | 10022752 | Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. | Pharmacogenetics | 1998 Apr |
4 |
| 25 | 10048600 | Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. | Naunyn Schmiedebergs Arch Pharmacol | 1999 Feb |
1 |
| 26 | 10385214 | Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5. | J Pharm Pharmacol | 1999 Apr |
3 |
| 27 | 10525096 | Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. | J Pharmacol Exp Ther | 1999 Nov |
4 |
| 28 | 10694240 | Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions. | Br J Pharmacol | 2000 Jan |
1 |
| 29 | 10696073 | Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. | Am J Respir Cell Mol Biol | 2000 Mar |
2 |
| 30 | 10815927 | Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans. | Clin Cancer Res | 2000 May |
6 |
| 31 | 10837558 | Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. | Adv Drug Deliv Rev | 1997 Sep 15 |
2 |
| 32 | 10898111 | Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans. | Pharmacogenetics | 2000 Jul |
1 |
| 33 | 11095583 | Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. | Drug Metab Dispos | 2000 Dec |
1 |
| 34 | 11294598 | Effect of trans-resveratrol on 7-benzyloxy-4-trifluoromethylcoumarin O-dealkylation catalyzed by human recombinant CYP3A4 and CYP3A5. | Can J Physiol Pharmacol | 2001 Mar |
7 |
| 35 | 11328961 | Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. | Physiol Genomics | 2001 Apr 27 |
2 |
| 36 | 11454902 | Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. | J Pharmacol Exp Ther | 2001 Aug |
4 |
| 37 | 11510493 | Apparent low frequency of sequence variability within the proximal promoter region of the cytochrome P450 (CYP) 3A5 gene in established cell lines from Japanese individuals. | Biol Pharm Bull | 2001 Aug |
1 |
| 38 | 11560868 | Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. | Drug Metab Dispos | 2001 Oct |
1 |
| 39 | 11744607 | Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. | Drug Metab Dispos | 2002 Jan |
1 |
| 40 | 11745908 | In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. | Biopharm Drug Dispos | 2001 Mar |
2 |
| 41 | 11861789 | NADPH-dependent metabolism of estrone by human liver microsomes. | J Pharmacol Exp Ther | 2002 Mar |
4 |
| 42 | 12040753 | Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. | Yakugaku Zasshi | 2002 May |
1 |
| 43 | 12065767 | Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. | Mol Pharmacol | 2002 Jul |
2 |
| 44 | 12124305 | Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. | Drug Metab Dispos | 2002 Aug |
1 |
| 45 | 12167563 | Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4. | Drug Metab Dispos | 2002 Sep |
3 |
| 46 | 12202670 | Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies. | J Clin Oncol | 2002 Sep 1 |
1 |
| 47 | 12379470 | Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin. | Mutat Res | 2002 Oct 31 |
2 |
| 48 | 12406645 | Genetic contribution to variable human CYP3A-mediated metabolism. | Adv Drug Deliv Rev | 2002 Nov 18 |
2 |
| 49 | 12419016 | Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites. | Xenobiotica | 2002 Oct |
4 |
| 50 | 12433801 | Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5. | Drug Metab Dispos | 2002 Dec |
1 |